Skip to main content
Top
Published in: Arthritis Research & Therapy 4/2007

Open Access 01-08-2007 | Research article

The ITGAVrs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study

Authors: Laurent Jacq, Sophie Garnier, Philippe Dieudé, Laëtitia Michou, Céline Pierlot, Paola Migliorini, Alejandro Balsa, René Westhovens, Pilar Barrera, Helena Alves, Carlos Vaz, Manuela Fernandes, Dora Pascual-Salcedo, Stefano Bombardieri, Jan Dequeker, Timothy R Radstake, Piet Van Riel, Leo van de Putte, Antonio Lopes-Vaz, Elodie Glikmans, Sandra Barbet, Sandra Lasbleiz, Isabelle Lemaire, Patrick Quillet, Pascal Hilliquin, Vitor Hugo Teixeira, Elisabeth Petit-Teixeira, Hamdi Mbarek, Bernard Prum, Thomas Bardin, François Cornélis, the European Consortium on Rheumatoid Arthritis Families

Published in: Arthritis Research & Therapy | Issue 4/2007

Login to get access

Abstract

The integrin αvβ3, whose αv subunit is encoded by the ITGAV gene, plays a key role in angiogenesis. Hyperangiogenesis is involved in rheumatoid arthritis (RA) and the ITGAV gene is located in 2q31, one of the suggested RA susceptibility loci. Our aim was to test the ITGAV gene for association and linkage to RA in a family-based study from the European Caucasian population.
Two single nucleotide polymorphisms were genotyped by PCR-restriction fragment length polymorphism in 100 French Caucasian RA trio families (one RA patient and both parents), 100 other French families and 265 European families available for replication. The genetic analyses for association and linkage were performed using the comparison of allelic frequencies (affected family-based controls), the transmission disequilibrium test, and the genotype relative risk.
We observed a significant RA association for the C allele of rs3738919 in the first sample (affected family-based controls, RA index cases 66.5% versus controls 56.7%; P = 0.04). The second sample showed the same trend, and the third sample again showed a significant RA association. When all sets were combined, the association was confirmed (affected family-based controls, RA index cases 64.6% versus controls 58.1%; P = 0.005). The rs3738919-C allele was also linked to RA (transmission disequilibrium test, 56.5% versus50% of transmission; P = 0.009) and the C-allele-containing genotype was more frequent in RA index cases than in controls (RA index cases 372 versus controls 339; P = 0.002, odds ratio = 1.94, 95% confidence interval = 1.3–2.9).
The rs3738919-C allele of the ITGAV gene is associated with RA in the European Caucasian population, suggesting ITGAV as a new minor RA susceptibility gene.
Literature
1.
go back to reference Seldin MF, Amos CI, Ward R, Gregersen PK: The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum. 1999, 42: 1071-1079. 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8.CrossRefPubMed Seldin MF, Amos CI, Ward R, Gregersen PK: The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum. 1999, 42: 1071-1079. 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8.CrossRefPubMed
2.
go back to reference Feldmann M, Brennan FM, Maini RN: Rheumatoid arthritis. Cell. 1996, 85: 307-331. 10.1016/S0092-8674(00)81109-5.CrossRefPubMed Feldmann M, Brennan FM, Maini RN: Rheumatoid arthritis. Cell. 1996, 85: 307-331. 10.1016/S0092-8674(00)81109-5.CrossRefPubMed
3.
go back to reference Dieudé P, Garnier S, Michou L, Petit-Teixeira E, Glikmans E, Pierlot C, Lasbleiz S, Bardin T, Prum B, Cornelis F: Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele. Arthritis Res Ther. 2005, 7: R1200-R1207. 10.1186/ar1812.PubMedCentralCrossRefPubMed Dieudé P, Garnier S, Michou L, Petit-Teixeira E, Glikmans E, Pierlot C, Lasbleiz S, Bardin T, Prum B, Cornelis F: Rheumatoid arthritis seropositive for the rheumatoid factor is linked to the protein tyrosine phosphatase nonreceptor 22-620W allele. Arthritis Res Ther. 2005, 7: R1200-R1207. 10.1186/ar1812.PubMedCentralCrossRefPubMed
4.
go back to reference Michou L, Croiseau P, Petit-Teixeira E, du Montcel ST, Lemaire I, Pierlot C, Osorio J, Frigui W, Lasbleiz S, Quillet P, et al: Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis. Arthritis Res Ther. 2006, 8: R79-10.1186/ar1949.PubMedCentralCrossRefPubMed Michou L, Croiseau P, Petit-Teixeira E, du Montcel ST, Lemaire I, Pierlot C, Osorio J, Frigui W, Lasbleiz S, Quillet P, et al: Validation of the reshaped shared epitope HLA-DRB1 classification in rheumatoid arthritis. Arthritis Res Ther. 2006, 8: R79-10.1186/ar1949.PubMedCentralCrossRefPubMed
5.
go back to reference Osorio Y, Fortea J, Bukulmez H, Petit-Teixeira E, Michou L, Pierlot C, Cailleau-Moindrault S, Lemaire I, Lasbleiz S, Alibert O, et al: Dense genome-wide linkage analysis of rheumatoid arthritis including covariates. Arthritis Rheum. 2004, 50: 2757-2765. 10.1002/art.20458.CrossRef Osorio Y, Fortea J, Bukulmez H, Petit-Teixeira E, Michou L, Pierlot C, Cailleau-Moindrault S, Lemaire I, Lasbleiz S, Alibert O, et al: Dense genome-wide linkage analysis of rheumatoid arthritis including covariates. Arthritis Rheum. 2004, 50: 2757-2765. 10.1002/art.20458.CrossRef
6.
go back to reference Eliceiri BP, Cherech DA: The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical developments. J Clin Invest. 1999, 103: 1227-1230.PubMedCentralCrossRefPubMed Eliceiri BP, Cherech DA: The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical developments. J Clin Invest. 1999, 103: 1227-1230.PubMedCentralCrossRefPubMed
7.
go back to reference Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA: Definition of two angiogenic pathways by distinct alpha v integrins. Science. 1995, 270: 1500-1502. 10.1126/science.270.5241.1500.CrossRefPubMed Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA: Definition of two angiogenic pathways by distinct alpha v integrins. Science. 1995, 270: 1500-1502. 10.1126/science.270.5241.1500.CrossRefPubMed
8.
go back to reference Bader BL, Rayburn H, Crowley D, Hynes RO: Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell. 1998, 95: 507-519. 10.1016/S0092-8674(00)81618-9.CrossRefPubMed Bader BL, Rayburn H, Crowley D, Hynes RO: Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell. 1998, 95: 507-519. 10.1016/S0092-8674(00)81618-9.CrossRefPubMed
9.
go back to reference Ballara S, Taylor PC, Reusch P, Marmé D, Feldmann M, Maini RN, Paleolog EM: Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum. 2001, 44: 2055-2064. 10.1002/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO;2-2.CrossRefPubMed Ballara S, Taylor PC, Reusch P, Marmé D, Feldmann M, Maini RN, Paleolog EM: Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum. 2001, 44: 2055-2064. 10.1002/1529-0131(200109)44:9<2055::AID-ART355>3.0.CO;2-2.CrossRefPubMed
10.
go back to reference Blake DR, Merry P, Unsworth J, Kidd BL, Outhwaite JM, Ballard R, Morris CJ, Gray L, Lunec J: Hypoxic-reperfusion injury in the inflamed human joint. Lancet. 1989, 1: 289-293. 10.1016/S0140-6736(89)91305-6.CrossRefPubMed Blake DR, Merry P, Unsworth J, Kidd BL, Outhwaite JM, Ballard R, Morris CJ, Gray L, Lunec J: Hypoxic-reperfusion injury in the inflamed human joint. Lancet. 1989, 1: 289-293. 10.1016/S0140-6736(89)91305-6.CrossRefPubMed
11.
go back to reference de Bandt M, Grossin M, Weber AJ, Chopin M, Elbim C, Pla M, Gougerot-Pocidalo MA, Gaudry M: Suppression of arthritis and protection from bone destruction by treatment with TNP-470/AGM-1470 in a transgenic mouse model of rheumatoid arthritis. Arthritis Rheum. 2000, 43: 2056-2063. 10.1002/1529-0131(200009)43:9<2056::AID-ANR17>3.0.CO;2-2.CrossRefPubMed de Bandt M, Grossin M, Weber AJ, Chopin M, Elbim C, Pla M, Gougerot-Pocidalo MA, Gaudry M: Suppression of arthritis and protection from bone destruction by treatment with TNP-470/AGM-1470 in a transgenic mouse model of rheumatoid arthritis. Arthritis Rheum. 2000, 43: 2056-2063. 10.1002/1529-0131(200009)43:9<2056::AID-ANR17>3.0.CO;2-2.CrossRefPubMed
12.
go back to reference Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI, Cheresh DA: Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest. 1999, 103: 47-54.PubMedCentralCrossRefPubMed Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI, Cheresh DA: Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest. 1999, 103: 47-54.PubMedCentralCrossRefPubMed
13.
go back to reference Gerlag DM, Borges E, Tak PP, Ellerby HM, Bredesen DE, Pasqualini R: Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res. 2001, 3: 357-361. 10.1186/ar327.PubMedCentralCrossRefPubMed Gerlag DM, Borges E, Tak PP, Ellerby HM, Bredesen DE, Pasqualini R: Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature. Arthritis Res. 2001, 3: 357-361. 10.1186/ar327.PubMedCentralCrossRefPubMed
14.
go back to reference Badger AM, Blake S, Kapadia R, Sarkar S, Levin J, Swift BA, Hoffman SJ, Stroup GB, Miller WH, Gowen M, et al: Disease-modifying activity of SB 27 an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis. Arthritis Rheum. 3005, 44: 128-137. 10.1002/1529-0131(200101)44:1<128::AID-ANR17>3.0.CO;2-M.CrossRef Badger AM, Blake S, Kapadia R, Sarkar S, Levin J, Swift BA, Hoffman SJ, Stroup GB, Miller WH, Gowen M, et al: Disease-modifying activity of SB 27 an orally active, nonpeptide alphavbeta3 (vitronectin receptor) antagonist, in rat adjuvant-induced arthritis. Arthritis Rheum. 3005, 44: 128-137. 10.1002/1529-0131(200101)44:1<128::AID-ANR17>3.0.CO;2-M.CrossRef
15.
go back to reference Wilder RL: Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann Rheum Dis. 2002, 61: ii96-ii99.PubMedCentralCrossRefPubMed Wilder RL: Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases. Ann Rheum Dis. 2002, 61: ii96-ii99.PubMedCentralCrossRefPubMed
16.
go back to reference Arnett FC, Edworthy SM, Bloch DA: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002/art.1780310302.CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002/art.1780310302.CrossRefPubMed
17.
go back to reference Gregersen PK, Silver J, Winchester RJ: The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987, 30: 1205-1213. 10.1002/art.1780301102.CrossRefPubMed Gregersen PK, Silver J, Winchester RJ: The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987, 30: 1205-1213. 10.1002/art.1780301102.CrossRefPubMed
18.
go back to reference Sambrook P, Fritsch E, Maniatis T: A Laboratory Manual. 1989, New York: Cold Spring Harbor Laboratory Press, 1: 2 Sambrook P, Fritsch E, Maniatis T: A Laboratory Manual. 1989, New York: Cold Spring Harbor Laboratory Press, 1: 2
21.
go back to reference Botstein D, White RL, Skolnick M, Davis RW: Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet. 1980, 32: 314-331.PubMedCentralPubMed Botstein D, White RL, Skolnick M, Davis RW: Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet. 1980, 32: 314-331.PubMedCentralPubMed
23.
go back to reference Garnier S, Dieudé P, Michou L, Barbet S, Tan A, Lasbleiz S, Bardin T, Prum B, Cornelis F: IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis. Ann Rheum Dis. 2007, 66: 828-831. 10.1136/ard.2006.061390.PubMedCentralCrossRefPubMed Garnier S, Dieudé P, Michou L, Barbet S, Tan A, Lasbleiz S, Bardin T, Prum B, Cornelis F: IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis. Ann Rheum Dis. 2007, 66: 828-831. 10.1136/ard.2006.061390.PubMedCentralCrossRefPubMed
24.
go back to reference Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993, 52: 506-516.PubMedCentralPubMed Spielman RS, McGinnis RE, Ewens WJ: Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 1993, 52: 506-516.PubMedCentralPubMed
Metadata
Title
The ITGAVrs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based study
Authors
Laurent Jacq
Sophie Garnier
Philippe Dieudé
Laëtitia Michou
Céline Pierlot
Paola Migliorini
Alejandro Balsa
René Westhovens
Pilar Barrera
Helena Alves
Carlos Vaz
Manuela Fernandes
Dora Pascual-Salcedo
Stefano Bombardieri
Jan Dequeker
Timothy R Radstake
Piet Van Riel
Leo van de Putte
Antonio Lopes-Vaz
Elodie Glikmans
Sandra Barbet
Sandra Lasbleiz
Isabelle Lemaire
Patrick Quillet
Pascal Hilliquin
Vitor Hugo Teixeira
Elisabeth Petit-Teixeira
Hamdi Mbarek
Bernard Prum
Thomas Bardin
François Cornélis
the European Consortium on Rheumatoid Arthritis Families
Publication date
01-08-2007
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2007
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2221

Other articles of this Issue 4/2007

Arthritis Research & Therapy 4/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.